Table 3.

The effect of the G haplotype on thrombin generation was determined after initiation at 1 pM TF in NIHR BioResource participants

CAT parameterVariableMedian (IQR)Wilcoxon rank sum P value
F5-G/G (n = 7)F5-ref (n = 13)
LT (min) No Ab (t−12.9 (10.2-20.2) 9.25 (8.62-11.0) .030∗ 
 Anti-TFPI (t+) 3.36 (3.29-4.11) 3.33 (3.13-3.70) .781 (N.S.) 
 Ratio (t−/t+3.86 (3.29-5.52) 2.80 (2.39-3.25) .0085∗∗ 
Peak (nM thrombin) No Ab 31.4 (19.9-42.7) 30.6 (20.3-49.7) 1.00 (N.S.) 
 Anti-TFPI 248 (234-282) 239 (200-269) .351 (N.S.) 
 Ratio 0.130 (0.0744-0.15) 0.133 (0.0854-0.177) .877 (N.S.) 
ttPeak (min) No Ab 17.6 (15.3-25.4) 15.8 (14.0-16.2) .115 (N.S.) 
 Anti-TFPI 6.14 (5.78-7.15) 6.03 (5.76-6.14) .485 (N.S.) 
 Ratio 2.99 (2.86-3.74) 2.57 (2.39-2.85) .030∗ 
ETP (nM thrombin × min) No Ab 367 (256-508) 410 (312-595) .643 (N.S.) 
 Anti-TFPI 1230 (1120-1350) 1120 (930-1180) .097 (N.S.) 
 Ratio 0.314 (0.195-0.441) 0.388 (0.306-0.526) .311 (N.S.) 
CAT parameterVariableMedian (IQR)Wilcoxon rank sum P value
F5-G/G (n = 7)F5-ref (n = 13)
LT (min) No Ab (t−12.9 (10.2-20.2) 9.25 (8.62-11.0) .030∗ 
 Anti-TFPI (t+) 3.36 (3.29-4.11) 3.33 (3.13-3.70) .781 (N.S.) 
 Ratio (t−/t+3.86 (3.29-5.52) 2.80 (2.39-3.25) .0085∗∗ 
Peak (nM thrombin) No Ab 31.4 (19.9-42.7) 30.6 (20.3-49.7) 1.00 (N.S.) 
 Anti-TFPI 248 (234-282) 239 (200-269) .351 (N.S.) 
 Ratio 0.130 (0.0744-0.15) 0.133 (0.0854-0.177) .877 (N.S.) 
ttPeak (min) No Ab 17.6 (15.3-25.4) 15.8 (14.0-16.2) .115 (N.S.) 
 Anti-TFPI 6.14 (5.78-7.15) 6.03 (5.76-6.14) .485 (N.S.) 
 Ratio 2.99 (2.86-3.74) 2.57 (2.39-2.85) .030∗ 
ETP (nM thrombin × min) No Ab 367 (256-508) 410 (312-595) .643 (N.S.) 
 Anti-TFPI 1230 (1120-1350) 1120 (930-1180) .097 (N.S.) 
 Ratio 0.314 (0.195-0.441) 0.388 (0.306-0.526) .311 (N.S.) 

Thrombin generation was assessed by CAT after initiation by 1 pM TF in citrated plasma, collected in CTI, in the presence and absence of inhibitory anti-TFPI Abs. The LT, ttPeak, peak, and ETP of thrombin generation were calculated. The mean of 3 technical replicates of each parameter was calculated for each participant and then group medians were determined, which are represented in the table. The ratio for each parameter corresponds to the value determined by dividing the measurement in the absence of anti-TFPI Abs by that made in its presence. The values in parentheses next to the median values represent the lower and upper limits of the IQR. N.B. ∗P < .05; ∗∗P < .01.

CTI, corn trypsin inhibitor; ETP, endogenous thrombin potential; N.S., not significant; ttPeak, time to peak.

Close Modal

or Create an Account

Close Modal
Close Modal